dalteparin has been researched along with Brain Vascular Disorders in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute cerebral ischemia was discovered to be the most common cerebrovascular disease associated with SARS-CoV-2." | 1.72 | Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies? ( Ates, O; Dogan, M; Ersoz, E; Hacioglu Kasim, FB; Karaarslan, N; Ozbek, H; Yilmaz, I, 2022) |
| "Inflammatory bowel diseases (IBD)--ulcerative colitis and Crohn's disease--are associated with increased risk for thrombotic complications both in the arterial and venous system." | 1.32 | [Cerebral sinus thrombosis and ulcerative colitis: two cases]. ( Debreczeni, R; Ilniczky, S; Kovács, T; Szirmai, I, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ilniczky, S | 1 |
| Debreczeni, R | 1 |
| Kovács, T | 1 |
| Szirmai, I | 1 |
| Kay, R | 2 |
| Wong, KS | 2 |
| Yu, YL | 1 |
| Chan, YW | 1 |
| Tsoi, TH | 1 |
| Ahuja, AT | 1 |
| Chan, FL | 1 |
| Fong, KY | 1 |
| Law, CB | 1 |
| Wong, A | 1 |
| Biller, J | 1 |
| Sherman, DG | 1 |
| Ates, O | 1 |
| Yilmaz, I | 1 |
| Karaarslan, N | 1 |
| Ersoz, E | 1 |
| Hacioglu Kasim, FB | 1 |
| Dogan, M | 1 |
| Ozbek, H | 1 |
| Bertini, G | 1 |
| Perugi, S | 1 |
| Dani, C | 1 |
| Prisco, D | 1 |
| Fonda, C | 1 |
2 reviews available for dalteparin and Brain Vascular Disorders
| Article | Year |
|---|---|
[Indication and management of anticoagulants in cerebrovascular disease].
Topics: Anticoagulants; Cerebrovascular Disorders; Heparin; Humans; Nadroparin | 1997 |
Heparin and heparinoids in stroke.
Topics: Anticoagulants; Cerebrovascular Disorders; Heparin; Humans; Nadroparin; Randomized Controlled Trials | 1998 |
1 trial available for dalteparin and Brain Vascular Disorders
| Article | Year |
|---|---|
Low-molecular-weight heparin for the treatment of acute ischemic stroke.
Topics: Activities of Daily Living; Acute Disease; Aged; Brain Ischemia; Cerebral Hemorrhage; Cerebral Infar | 1995 |
4 other studies available for dalteparin and Brain Vascular Disorders
| Article | Year |
|---|---|
[Cerebral sinus thrombosis and ulcerative colitis: two cases].
Topics: Adult; Anticoagulants; Cerebrovascular Disorders; Colitis, Ulcerative; Female; Humans; Magnetic Reso | 2003 |
Low-molecular-weight heparin and serum potassium.
Topics: Anticoagulants; Brain Ischemia; Cerebrovascular Disorders; Humans; Nadroparin; Potassium | 1997 |
Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies?
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; COVID-19; Enoxaparin; Humans; Manni | 2022 |
Cerebral venous thrombosis treated with enoxaparin in an IUGR neonate with DIC.
Topics: Anticoagulants; Brain; Cerebral Hemorrhage; Cerebral Veins; Cerebrovascular Disorders; Disseminated | 2009 |